临床HIV治疗中单片与多片抗逆转录病毒治疗方案的比较效果
Comparative effectiveness of single versus multiple tablet antiretroviral therapy regimens in clinical HIV practice.
作者信息
Drozd Daniel R, Saag Michael S, Westfall Andrew O, Mathews William Chris, Haubrich Richard, Boswell Stephen L, Cole Stephen R, Porter Donna, Kitahata Mari M, Juday Timothy, Rosenblatt Lisa
机构信息
Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA Division of Infectious Diseases Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL Department of Medicine, University of California San Diego, San Diego Gilead Sciences, Foster City, CA Fenway Health Center, Harvard Medical School, Boston, MA Department of Epidemiology, University of North Carolina, Chapel Hill, NC Bristol-Myers Squibb, Princeton, NJ.
出版信息
Medicine (Baltimore). 2017 Apr;96(14):e6275. doi: 10.1097/MD.0000000000006275.
Abstract
We determined risk of virologic failure (VF) in individuals initiating tenofovir/emtricitabine/efavirenz as single versus multiple tablet regimens (MTR). We found no significant difference in the risk of VF, though did observe a trend toward more VF and M184 V mutations among persons initiating MTR. Temporal trends in care may have confounded results.
摘要
我们确定了开始使用替诺福韦/恩曲他滨/依非韦伦单一片剂方案（STR）与多片剂型方案（MTR）的个体发生病毒学失败（VF）的风险。我们发现VF风险无显著差异，不过确实观察到开始使用MTR的人群中VF和M184V突变有增加的趋势。治疗的时间趋势可能混淆了结果。
相似文献
1
Comparative effectiveness of single versus multiple tablet antiretroviral therapy regimens in clinical HIV practice.临床HIV治疗中单片与多片抗逆转录病毒治疗方案的比较效果
Medicine (Baltimore). 2017 Apr;96(14):e6275. doi: 10.1097/MD.0000000000006275.
2
Effectiveness of Single- and Multiple-Tablet Antiretroviral Regimens in Correctional Setting for Treatment-Experienced HIV Patients.单一片剂和多片剂抗逆转录病毒治疗方案在惩教机构中对有治疗经验的HIV患者的有效性。
J Correct Health Care. 2018 Jan;24(1):52-61. doi: 10.1177/1078345817745334. Epub 2017 Dec 14.
3
4
Cost-effectiveness of initial antiretroviral treatment administered as single vs. multiple tablet regimens with the same or different components.采用相同或不同成分的单片与多片方案进行初始抗逆转录病毒治疗的成本效益。
Enferm Infecc Microbiol Clin (Engl Ed). 2018 Jan;36(1):16-20. doi: 10.1016/j.eimc.2016.07.006. Epub 2016 Aug 29.
5
Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV.替诺福韦酯、恩曲他滨和依非韦伦与齐多夫定、拉米夫定和依非韦伦治疗HIV的比较
N Engl J Med. 2006 Jan 19;354(3):251-60. doi: 10.1056/NEJMoa051871.
6
Simplification to single-tablet regimen of elvitegravir, cobicistat, emtricitabine, tenofovir DF from multi-tablet ritonavir-boosted protease inhibitor plus coformulated emtricitabine and tenofovir DF regimens: week 96 results of STRATEGY-PI.将多片利托那韦增强型蛋白酶抑制剂联合恩曲他滨和替诺福韦酯复方制剂简化为埃替格韦、考比司他、恩曲他滨、替诺福韦酯单片复方制剂：STRATEGY-PI研究96周结果
HIV Clin Trials. 2017 May;18(3):118-125. doi: 10.1080/15284336.2017.1330440. Epub 2017 May 30.
7
Superior Effectiveness of Zidovudine Compared With Tenofovir When Combined With Nevirapine-based Antiretroviral Therapy in a Large Nigerian Cohort.在尼日利亚一个大型队列中，与替诺福韦相比，齐多夫定与基于奈韦拉平的抗逆转录病毒疗法联合使用时疗效更佳。
Clin Infect Dis. 2016 Feb 15;62(4):512-8. doi: 10.1093/cid/civ928. Epub 2015 Nov 10.
8
Adherence among rural HIV-infected patients in the deep south: a comparison between single-tablet and multi-tablet once-daily regimens.泰国南部农村地区艾滋病毒感染患者的治疗依从性：单片剂与多片剂每日一次治疗方案的比较
J Int Assoc Provid AIDS Care. 2015 Jan-Feb;14(1):64-71. doi: 10.1177/2325957414555228. Epub 2014 Oct 20.
9
Week 48 results from a randomized clinical trial of rilpivirine/emtricitabine/tenofovir disoproxil fumarate vs. efavirenz/emtricitabine/tenofovir disoproxil fumarate in treatment-naive HIV-1-infected adults.初治的HIV-1感染成人中，rilpivirine/恩曲他滨/替诺福韦酯与依法韦仑/恩曲他滨/替诺福韦酯对比的随机临床试验第48周结果。
AIDS. 2014 Apr 24;28(7):989-97. doi: 10.1097/QAD.0000000000000169.
10
Patient-reported outcomes in the single-tablet regimen (STaR) trial of rilpivirine/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate in antiretroviral treatment-naive adults infected with HIV-1 through 48 weeks of treatment.在初治的HIV-1感染成年患者中，进行的rilpivirine/恩曲他滨/富马酸替诺福韦二吡呋酯单一片剂方案（STaR）试验与依法韦仑/恩曲他滨/富马酸替诺福韦二吡呋酯对比，治疗48周的患者报告结局。
AIDS Care. 2016;28(3):401-8. doi: 10.1080/09540121.2015.1096890. Epub 2015 Oct 21.
引用本文的文献
1
Comparative safety of B/F/TAF versus other antiretroviral therapy regimens for treatment-naïve people with HIV-1: a systematic literature review and network meta-analysis.对于初治的HIV-1感染者，B/F/TAF与其他抗逆转录病毒治疗方案的比较安全性：一项系统文献综述和网状荟萃分析
J Comp Eff Res. 2025 Jul;14(7):e240231. doi: 10.57264/cer-2024-0231. Epub 2025 May 30.
2
One Pill, Once a Day: Simplified Treatment Regimens and Retention in HIV Care.每日一片：简化治疗方案与艾滋病护理中的留存率
Am J Epidemiol. 2022 May 20;191(6):999-1008. doi: 10.1093/aje/kwac006.
3
Real-world adherence and persistence for newly-prescribed HIV treatment: single versus multiple tablet regimen comparison among US medicaid beneficiaries.新处方 HIV 治疗的真实世界依从性和持久性：美国医疗补助受益人群中单一片剂与多片剂方案比较。
AIDS Res Ther. 2020 Apr 1;17(1):12. doi: 10.1186/s12981-020-00268-1.
本文引用的文献
1
Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society-USA Panel.成人 HIV 感染的抗逆转录病毒治疗：美国国际抗病毒学会 2014 年推荐意见。
JAMA. 2014;312(4):410-25. doi: 10.1001/jama.2014.8722.
2
Lower pill burden and once-daily antiretroviral treatment regimens for HIV infection: A meta-analysis of randomized controlled trials.降低HIV感染的药丸负担及每日一次抗逆转录病毒治疗方案：随机对照试验的荟萃分析
Clin Infect Dis. 2014 May;58(9):1297-307. doi: 10.1093/cid/ciu046. Epub 2014 Jan 22.
3
Adherence to antiretroviral treatment and correlation with risk of hospitalization among commercially insured HIV patients in the United States.美国商业保险的 HIV 患者抗逆转录病毒治疗的依从性与住院风险的相关性。
PLoS One. 2012;7(2):e31591. doi: 10.1371/journal.pone.0031591. Epub 2012 Feb 24.
4
A single tablet regimen is associated with higher adherence and viral suppression than multiple tablet regimens in HIV+ homeless and marginally housed people.单片治疗方案与多片治疗方案相比，在 HIV 阳性的无家可归者和边缘居住者中具有更高的依从性和病毒抑制率。
AIDS. 2010 Nov 27;24(18):2835-40. doi: 10.1097/QAD.0b013e328340a209.
5
Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel.成人 HIV 感染的抗逆转录病毒治疗：国际艾滋病协会-美国小组 2010 年的建议。
JAMA. 2010 Jul 21;304(3):321-33. doi: 10.1001/jama.2010.1004.
6
Simplification of antiretroviral therapy to a single-tablet regimen consisting of efavirenz, emtricitabine, and tenofovir disoproxil fumarate versus unmodified antiretroviral therapy in virologically suppressed HIV-1-infected patients.在病毒学抑制的HIV-1感染患者中，将抗逆转录病毒疗法简化为包含依非韦伦、恩曲他滨和替诺福韦酯富马酸盐的单片复方制剂与未调整的抗逆转录病毒疗法的比较。
J Acquir Immune Defic Syndr. 2009 Jun 1;51(2):163-74. doi: 10.1097/QAI.0b013e3181a572cf.
7
Increased regimen durability in the era of once-daily fixed-dose combination antiretroviral therapy.在每日一次固定剂量联合抗逆转录病毒治疗时代，治疗方案的耐用性增强。
AIDS. 2008 Oct 1;22(15):1951-60. doi: 10.1097/QAD.0b013e32830efd79.
8
Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel.成人HIV感染的抗逆转录病毒治疗：美国国际艾滋病协会专家组2008年建议
JAMA. 2008 Aug 6;300(5):555-70. doi: 10.1001/jama.300.5.555.
9
Cohort profile: the Centers for AIDS Research Network of Integrated Clinical Systems.队列简介：综合临床系统艾滋病研究网络中心
Int J Epidemiol. 2008 Oct;37(5):948-55. doi: 10.1093/ije/dym231. Epub 2008 Feb 8.
10
Pharmacy-based assessment of adherence to HAART predicts virologic and immunologic treatment response and clinical progression to AIDS and death.基于药房的高效抗逆转录病毒治疗依从性评估可预测病毒学和免疫学治疗反应以及向艾滋病和死亡的临床进展。
Int J STD AIDS. 2004 Dec;15(12):803-10. doi: 10.1258/0956462042563666.
Zotero 插件